![]() ![]() The Company has active programs in critical patient care, acute pain management, long acting injectables, and hospital injectables. Nevakar Injectables is developing a broad portfolio of injectable products for use in the hospital and ambulatory care settings. is a wholly owned subsidiary of Nevakar, Inc., a fully integrated privately held, late-stage biopharmaceutical company with an extensive portfolio of products in the ophthalmic and injectable areas. Learn more at About Nevakar Injectables, Inc. generics industry, possesses an expanding portfolio that includes sterile injectables, alternative dosage forms and other differentiated products. Par Pharmaceutical develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Learn more at connect with us on LinkedIn. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. Food and Drug Administration, and EVL is responsible for product launch and distribution through Endo's Par Sterile Products business.Įndo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Nevakar is responsible for developing the drugs and obtaining approval from the U.S. ![]() Under the agreement, the companies are collaborating on five differentiated sterile injectable products in the U.S. This is the first product launch under the previously announced exclusive licensing agreement between Nevakar Injectables, Inc., a privately held biopharmaceutical company, and Endo's subsidiary, Endo Ventures Limited (EVL). This may reduce waste and costs, optimize convenience and workflow, and heighten accuracy and compliance by reducing the chance for preparation error-all of which support quality patient care. Ready-to-use, or RTU, products help streamline operations for hospitals by eliminating the need to prepare or transfer the product before patient administration. "This is a demonstration of our commitment to deliver quality, life-enhancing therapies to healthcare providers-when and how they need them." "We are pleased to launch this new ready-to-use product as part of our agreement with Nevakar," said Scott Sims, Senior Vice President and General Manager, Sterile Products at Endo. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |